McKesson stock falls 2.47% and underperforms rivals
Updated
Updated · MarketWatch · May 8
McKesson stock falls 2.47% and underperforms rivals
6 articles · Updated · MarketWatch · May 8
Shares closed at $736.09 as the S&P 500 rose 0.84% and the Dow Jones Industrial Average added 0.02% in a broadly positive session.
McKesson lagged Amazon, UnitedHealth and CVS, whose shares all gained, while trading volume reached 2.1 million, above its 50-day average of 849,253.
The stock finished 26.32% below its 52-week high of $999, reached on 3 March, underscoring weaker recent momentum despite strong broader market conditions.
After announcing record earnings and a bright future, why did McKesson’s stock take a mysterious dive?
Is McKesson's pivot from drug distributor to a high-tech care platform a genius move or a massive gamble?